SCHEMBL27375754

SCHEMBL27375754

CC(O)[C@@H](O)n1cnc2c(=S)[nH]c(N)nc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 4/20 0.39
CDK2 P24941 4/20 0.39
CCNB1 P14635 2/20 0.39
CCNE1 P24864 2/20 0.39
HPRT1 P00492 3/20 0.38
HSD17B10 Q99714 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
PI4KA P42356 1/20 0.34
PI4K2B Q8TCG2 1/20 0.34
PI4K2A Q9BTU6 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
XDH P47989 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16769795 0.85 CDK2 (0.54) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL22381492 0.84 CDK1 (0.42) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL27374918 0.82 CDK1 (0.40) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL27374408 0.82 HPRT1 (0.40) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL18458052 0.81 ADORA2A (0.52) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL27374373 0.81 ADORA2A (0.52) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL10048814 0.80 BLM (0.38) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL27374338 0.80 HPRT1 (0.39) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL27375698 0.80 ADORA2A (0.39) CDK1CDK2CCNB1CCNE1HPRT1
SCHEMBL3291325 0.74 CDK1 (0.47) CDK1CDK2CCNB1CCNE1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024015941-A2 DINUCLEOTIDES AND THEIR USE IN TREATING CANCER MAIA BIOTECHNOLOGY, INC. (US) 2024-01-18 WO disclosed